Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs
Paul Bastard, Sara E. Vazquez, Jamin Liu, et al.
Science Immunology (2022) Vol. 8, Iss. 90
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread
Jean‐Laurent Casanova, Laurent Abel
Cell (2022) Vol. 185, Iss. 17, pp. 3086-3103
Open Access | Times Cited: 101
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
Qian Zhang, Andrés Pizzorno, Lisa Miorin, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 11
Open Access | Times Cited: 74
Autoantibodies neutralizing type I IFNs underlie West Nile virus encephalitis in ∼40% of patients
Adrian Gervais, Francesca Rovida, Maria Antonietta Avanzini, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 54
Covid-19 a triggering factor of autoimmune and multi-inflammatory diseases
Emina Karahmet Sher, Adnan Ćosović, Amina Džidić-Krivić, et al.
Life Sciences (2023) Vol. 319, pp. 121531-121531
Open Access | Times Cited: 42
Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs
Jean‐Laurent Casanova, Mark S. Anderson
Journal of Clinical Investigation (2023) Vol. 133, Iss. 3
Open Access | Times Cited: 40
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children
Paul Bastard, Adrian Gervais, Maki Taniguchi, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 22
Human autoantibodies neutralizing type I IFNs: From 1981 to 2023
Paul Bastard, Adrian Gervais, Tom Le Voyer, et al.
Immunological Reviews (2024) Vol. 322, Iss. 1, pp. 98-112
Open Access | Times Cited: 20
The ouroboros of autoimmunity
Jean‐Laurent Casanova, Jessica N. Peel, Jean Donadieu, et al.
Nature Immunology (2024) Vol. 25, Iss. 5, pp. 743-754
Closed Access | Times Cited: 16
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α
Alexis Mathian, Paul Breillat, Karim Dorgham, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 12, pp. 1695-1703
Open Access | Times Cited: 59
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia
Ana García‐García, Rebeca Pérez de Diego, Carlos Flores, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 5
Open Access | Times Cited: 34
Interfering with Interferons: A Critical Mechanism for Critical COVID-19 Pneumonia
Helen C. Su, Huie Jing, Yu Zhang, et al.
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 561-585
Open Access | Times Cited: 31
COVID-19 annual update: a narrative review
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 28
Innate immunity and interferon in SARS-CoV-2 infection outcome
Ram Savan, Michael Gale
Immunity (2023) Vol. 56, Iss. 7, pp. 1443-1450
Open Access | Times Cited: 25
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
Dennyson Leandro M. Fonseca, Igor Salerno Filgueiras, Alexandre H. C. Marques, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 22
Autoantibodies targeting type I interferons: Prevalence, mechanisms of induction, and association with viral disease susceptibility
Benjamin G. Hale
European Journal of Immunology (2023) Vol. 53, Iss. 6
Open Access | Times Cited: 21
Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination
Aurélien Sokal, Paul Bastard, Pascal Chappert, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 31
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Stuart G. Tangye, Laurent Abel, Salah Al-Muhsen, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 151, Iss. 4, pp. 818-831
Open Access | Times Cited: 29
Clinical and Immunological Features of SARS-CoV-2 Breakthrough Infections in Vaccinated Individuals Requiring Hospitalization
Giulia Lamacchia, Alessio Mazzoni, Michele Spinicci, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 7, pp. 1379-1391
Open Access | Times Cited: 28
Multisystem inflammatory syndrome in children (MIS-C): Implications for long COVID
Tamás Constantin, Tamás Pék, Zsuzsanna Horváth, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2221-2236
Open Access | Times Cited: 17
Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia
Martti Vanker, Karita Särekannu, Arnaud Fekkar, et al.
Journal of Interferon & Cytokine Research (2023) Vol. 43, Iss. 9, pp. 379-393
Open Access | Times Cited: 16
Type I and type III interferons: From basic biology and genetics to clinical development for COVID-19 and beyond
Evangelos Andreakos
Seminars in Immunology (2024) Vol. 72, pp. 101863-101863
Closed Access | Times Cited: 5
Coronavirus disease 2019 (COVID-19) pandemic and autoimmune rheumatic diseases: Outcomes and prospects
Е. Л. Насонов
Rheumatology Science and Practice (2024) Vol. 62, Iss. 1, pp. 32-54
Open Access | Times Cited: 5
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
The type I IFN-IL-27 axis promotes mRNA vaccine-induced CD8+T cell responses
Anthony T. Phan, Emily Aunins, Elisa Cruz-Morales, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Prevalence of EBV, HHV6, HCMV, HAdV, SARS-CoV-2, and Autoantibodies to Type I Interferon in Sputum from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
Ulf Hannestad, Annika Allard, Kent W. Nilsson, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 422-422
Open Access
Page 1 - Next Page

Scroll to top